Abstract -Starting from natural asparagine, an efficient synthesis of the dibenzyl protected 6-amino-l,3-oxazepin-4-one (7) is reported. According to NMR based conformational studies, the lactam-bridged J3-amino acid analog (7) adopts preferentially a twisted boat structure. The incorporation of the described molecular scaffold to give a constrained J3-analog of the dopamine receptor modulating peptide
s As an example, the y-Iactam restricted analog (1) of the dopamine receptor modulating peptide Pro-Leu-Gly-NH z (PLG) displayed modulating activities superior to PLG, indicating that a type-II J3-tum might be bioactive conformation. 9 . ,o Structure activity relationship studies in our laboratory are based on J3-amino acid derived PLG analogs including the incorporation of J3-proline as well as 4-aminopiperidin-2-one as a Homo-Freidinger lactam (2).11.12
As an extension of our efforts on the synthesis of conformationally restrained J3-amino acid equivalents, here we report the construction of enantiopure 6-amino-I ,3-oxazepin-4-ones lJ from natural asparagine and the application of this novel molecular scaffold for the respective PLG analog (3). formed by H-6 and H-5b with quasi axial orientation of these two protons.
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Furthermore, strong NOEs between the protons of one of the methyl groups and H-5b and the protons of the other methyl group and H-7a were measured, suggesting a conformation of 7 as shown in Figure I , which is also in good agreement with all the other observed coupling constants and NOEs.
Figure 1 Conformational representation of compound (7) as derived from NOE experiments and IH NMR coupling constants
As an example for the incorporation of the chiral building block (7) into a constrained peptidomimetic, the synthesis of the PLG surrogate (3) was elaborated. Compound (7) was easily converted into the dipeptidomimetic (9) by deprotonation with NaH and subsequent reaction with ethyl bromoacetate.
Hydrogenolytic cleavage of the dibenzylamine group of 9 with 10 % PdlC as the catalyst afforded the primary amine (10), which was coupled with Cbz-proline to give the tripeptidomimetic (12) in good yield.
Deprotection of the prolyl moiety followed by aminolysis of the glycine ester yielded the target compound (3). This pathway is superior to the reversed reaction sequence including aminolysis as the first step and subsequent hydrogenolytic deprotection of the tripeptidomimetic amide, which gave poorly separable mixtures.
Compound (7) also enables a simple but effective approach to peptidomimetics containing homo serine as an amino acid analog by hydrolysis of the cyclic NIO-acetal. Thus, treating (12) with diluted HCl resulted in the formation of the PLG analogue (13) . However, as a building block of potential pharmaceutical use, the oxazepane (7) and especially its N-alkylated derivatives should resist hydrolysis under physiological conditions. It could be shown that treatment with aqueous citric acid (10%) resulted in rapid hydrolysis of unsubstituted 7, whereas the rate of decomposition of 3-N-methyl-7 was much slower. The glycine ester derivative (9) resisted the same conditions even for five days and more, demonstrating sufficiant stability of the oxazepane moiety in the aspired peptidomimetics. All oxazepanes were completely stable against water and mild bases. Csing the same reaction conditiones but p-toluenesulfonic acid hydrate as the catalyst, chromatographic separation of the products afforded 7 (66 mg, 259c), besides 6 (42 mg. 30%) and 8 (4 mg, 1.5%). 
A solution of compound (5) 
